Litcius/Paper detail

Tofacitinib-induced remission in refractory adult-onset Still’s disease complicated by macrophage activation syndrome

Manabu Honda, Mayuko Moriyama, Masahiro Kondo, Shunichi Kumakura, Yohko Murakawa

2020Scandinavian Journal of Rheumatology24 citationsDOI

Abstract

Adult-onset Still’s disease (AOSD) is rarely complicated by macrophage activation syndrome (MAS), which is also called secondary haemophagocytic lymphohistiocytosis (HLH) (1, 2). MAS is a life-thre...

Topics & Concepts

Macrophage activation syndromeMedicineAdult-onset Still's diseaseRefractory (planetary science)Hemophagocytic lymphohistiocytosisTofacitinibDiseaseImmunologyMacrophagePediatricsInternal medicineBiochemistryIn vitroAstrobiologyPhysicsChemistryRheumatoid arthritisAutoimmune and Inflammatory Disorders ResearchImmune Cell Function and InteractionAdolescent and Pediatric Healthcare
Tofacitinib-induced remission in refractory adult-onset Still’s disease complicated by macrophage activation syndrome | Litcius